The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for...
The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL)
About this item
Full title
Author / Creator
Okushin, Kazuya , Tateishi, Ryosuke , Hirakawa, Shinya , Tachimori, Hisateru , Uchino, Koji , Nakagomi, Ryo , Yamada, Tomoharu , Nakatsuka, Takuma , Minami, Tatsuya , Sato, Masaya , Fujishiro, Mitsuhiro , Hasegawa, Kiyoshi , Eguchi, Yuichiro , Kanto, Tatsuya , Yoshiji, Hitoshi , Izumi, Namiki , Kudo, Masatoshi and Koike, Kazuhiko
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The number of cancer cases diagnosed during the coronavirus disease 2019 (COVID-19) pandemic has decreased. This study investigated the impact of the pandemic on the clinical practice of hepatocellular carcinoma (HCC) using a novel nationwide REgistry for Advanced Liver diseases (REAL) in Japan. We retrieved data of patients initially diagnosed wit...
Alternative Titles
Full title
The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_faac6bf7b5d942c8a81978239c425eca
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_faac6bf7b5d942c8a81978239c425eca
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-024-53199-6
